B S Spinowitz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B S Spinowitz

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Pharmacotherapy|June 10, 1998

Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysisM H Schwenk, A Q Jumani, C R Rosenberg, et al.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2000

Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trialD B Van Wyck, G Cavallo, B S Spinowitz, et al.

Controlled Clinical Trials|September 30, 1999

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)B I Freedman, J P Wuerth, K Cartwright, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Pharmacotherapy|June 10, 1998

Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysisM H Schwenk, A Q Jumani, C R Rosenberg, et al.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2000

Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trialD B Van Wyck, G Cavallo, B S Spinowitz, et al.

Controlled Clinical Trials|September 30, 1999

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)B I Freedman, J P Wuerth, K Cartwright, et al.

Pageof 3